COVER
COVER - shares | 6 Months Ended | |
Jun. 30, 2023 | Aug. 04, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-40581 | |
Entity Registrant Name | FREYR Battery | |
Entity Incorporation, State or Country Code | N4 | |
Entity Address, Address Line One | 22-24, Boulevard Royal | |
Entity Address, Postal Zip Code | -2449 | |
Entity Address, City or Town | Luxembourg | |
Entity Address, Country | LU | |
City Area Code | 352 | |
Local Phone Number | 46 61 11 3721 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 139,705,234 | |
Entity Central Index Key | 0001844224 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q2 | |
Entity Tax Identification Number | 00-0000000 | |
Amendment Flag | false | |
Entity Tax Identification Number | 00-0000000 | |
Ordinary Shares, without nominal value | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Ordinary Shares, without nominal value | |
Trading Symbol | FREY | |
Security Exchange Name | NYSE | |
Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 | |
Trading Symbol | FREY WS | |
Security Exchange Name | NYSE |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 334,364 | $ 443,063 |
Restricted cash | 49,425 | 119,982 |
Prepaid assets | 4,250 | 8,293 |
Other current assets | 6,845 | 8,117 |
Total current assets | 394,884 | 579,455 |
Property and equipment, net | 320,007 | 210,777 |
Intangible assets, net | 2,888 | 2,963 |
Long-term investments | 22,628 | 0 |
Convertible note | 0 | 19,954 |
Right-of-use asset under operating leases | 23,431 | 14,538 |
Other long-term assets | 9 | 11 |
Total assets | 763,847 | 827,698 |
Current liabilities: | ||
Accounts payable | 20,162 | 6,765 |
Accrued liabilities and other | 32,510 | 51,446 |
Share-based compensation liability | 4,570 | 4,367 |
Total current liabilities | 57,242 | 62,578 |
Warrant liability | 34,939 | 33,849 |
Operating lease liability | 18,632 | 11,144 |
Other long-term liabilities | 20,145 | 0 |
Total liabilities | 130,958 | 107,571 |
Commitments and contingencies | ||
Shareholders’ equity: | ||
Ordinary share capital, no par value, 245,000 ordinary shares authorized, and 139,854 and 139,705 ordinary shares issued and outstanding, respectively, as of both June 30, 2023 and December 31, 2022 | 139,854 | 139,854 |
Additional paid-in capital | 777,813 | 772,602 |
Treasury stock | (1,041) | (1,041) |
Accumulated other comprehensive (loss) income | (45,049) | 9,094 |
Accumulated deficit | (241,062) | (203,054) |
Total ordinary shareholders' equity | 630,515 | 717,455 |
Non-controlling interests | 2,374 | 2,672 |
Total equity | 632,889 | 720,127 |
Total liabilities and equity | $ 763,847 | $ 827,698 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Ordinary share capital, par value (in USD per share) | $ 0 | $ 0 |
Ordinary share capital, shares authorized (in shares) | 245,000 | 245,000 |
Ordinary share capital, shares issued (in shares) | 139,854 | 139,854 |
Ordinary share capital, shares outstanding (in shares) | 139,705 | 139,705 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Operating expenses: | ||||
General and administrative | $ 27,631 | $ 28,150 | $ 57,633 | $ 52,764 |
Research and development | 6,365 | 3,082 | 11,209 | 5,941 |
Share of net loss of equity method investee | 30 | 296 | 55 | 463 |
Total operating expenses | 34,026 | 31,528 | 68,897 | 59,168 |
Loss from operations | (34,026) | (31,528) | (68,897) | (59,168) |
Other income (expense): | ||||
Warrant liability fair value adjustment | (2,556) | 33,392 | (1,151) | 24,704 |
Convertible note fair value adjustment | 0 | 270 | 1,074 | 491 |
Interest income, net | 1,755 | 14 | 4,758 | 29 |
Foreign currency transaction gain | 7,711 | 1,421 | 23,759 | 1,090 |
Other income, net | 1,851 | 1,102 | 2,492 | 2,618 |
Total other income (expense) | 8,761 | 36,199 | 30,932 | 28,932 |
(Loss) income before income taxes | (25,265) | 4,671 | (37,965) | (30,236) |
Income tax expense | (138) | 0 | (341) | 0 |
Net (loss) income | (25,403) | 4,671 | (38,306) | (30,236) |
Net loss attributable to non-controlling interests | 121 | 0 | 298 | 0 |
Net (loss) income attributable to ordinary shareholders | $ (25,282) | $ 4,671 | $ (38,008) | $ (30,236) |
Weighted average ordinary shares outstanding: | ||||
Weighted average ordinary shares outstanding - basic (in shares) | 139,705,000 | 116,830,000 | 139,705,000 | 116,842,000 |
Weighted average ordinary shares outstanding - diluted (in shares) | 139,705,000 | 119,250,000 | 139,705,000 | 116,842,000 |
Net (loss) income per share: | ||||
Net (loss) income attributable to ordinary shareholders per share - basic (in USD per share) | $ (0.18) | $ 0.04 | $ (0.27) | $ (0.26) |
Net (loss) income attributable to ordinary shareholders per share - diluted (in USD per share) | $ (0.18) | $ 0.04 | $ (0.27) | $ (0.26) |
Other comprehensive income (loss): | ||||
Net (loss) income | $ (25,403) | $ 4,671 | $ (38,306) | $ (30,236) |
Foreign currency translation adjustments | (20,425) | (7,791) | (54,143) | (7,458) |
Total comprehensive loss | (45,828) | (3,120) | (92,449) | (37,694) |
Comprehensive loss attributable to non-controlling interests | 121 | 0 | 298 | 0 |
Comprehensive loss attributable to ordinary shareholders | $ (45,707) | $ (3,120) | $ (92,151) | $ (37,694) |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Ordinary Shares | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Treasury Stock | Accumulated Deficit | Non-controlling interests |
Shares outstanding, beginning balance (in shares) at Dec. 31, 2021 | 116,854 | ||||||
Equity, beginning balance at Dec. 31, 2021 | $ 545,485 | $ 116,854 | $ 533,418 | $ (524) | $ 0 | $ (104,263) | $ 0 |
Share-based compensation expense | 850 | 850 | |||||
Net (loss) income | (34,907) | (34,907) | |||||
Other comprehensive income (loss) | 333 | 333 | |||||
Shares outstanding, ending balance (in shares) at Mar. 31, 2022 | 116,854 | ||||||
Equity, ending balance at Mar. 31, 2022 | 511,761 | $ 116,854 | 534,268 | (191) | 0 | (139,170) | 0 |
Shares outstanding, beginning balance (in shares) at Dec. 31, 2021 | 116,854 | ||||||
Equity, beginning balance at Dec. 31, 2021 | 545,485 | $ 116,854 | 533,418 | (524) | 0 | (104,263) | 0 |
Net (loss) income | (30,236) | ||||||
Shares outstanding, ending balance (in shares) at Jun. 30, 2022 | 116,854 | ||||||
Equity, ending balance at Jun. 30, 2022 | 512,960 | $ 116,854 | 539,639 | (7,982) | (1,052) | (134,499) | 0 |
Shares outstanding, beginning balance (in shares) at Mar. 31, 2022 | 116,854 | ||||||
Equity, beginning balance at Mar. 31, 2022 | 511,761 | $ 116,854 | 534,268 | (191) | 0 | (139,170) | 0 |
Share-based compensation expense | 5,371 | 5,371 | |||||
Net (loss) income | 4,671 | 4,671 | |||||
Repurchase of shares | (1,052) | (1,052) | |||||
Other comprehensive income (loss) | (7,791) | (7,791) | |||||
Shares outstanding, ending balance (in shares) at Jun. 30, 2022 | 116,854 | ||||||
Equity, ending balance at Jun. 30, 2022 | $ 512,960 | $ 116,854 | 539,639 | (7,982) | (1,052) | (134,499) | 0 |
Shares outstanding, beginning balance (in shares) at Dec. 31, 2022 | 139,705 | 139,854 | |||||
Equity, beginning balance at Dec. 31, 2022 | $ 720,127 | $ 139,854 | 772,602 | 9,094 | (1,041) | (203,054) | 2,672 |
Share-based compensation expense | 1,462 | 1,462 | |||||
Net (loss) income | (12,903) | (12,726) | (177) | ||||
Reclassification of warrants from liability classified to equity classified | 5 | 5 | |||||
Other comprehensive income (loss) | (33,718) | (33,718) | |||||
Shares outstanding, ending balance (in shares) at Mar. 31, 2023 | 139,854 | ||||||
Equity, ending balance at Mar. 31, 2023 | $ 674,973 | $ 139,854 | 774,069 | (24,624) | (1,041) | (215,780) | 2,495 |
Shares outstanding, beginning balance (in shares) at Dec. 31, 2022 | 139,705 | 139,854 | |||||
Equity, beginning balance at Dec. 31, 2022 | $ 720,127 | $ 139,854 | 772,602 | 9,094 | (1,041) | (203,054) | 2,672 |
Net (loss) income | $ (38,306) | ||||||
Shares outstanding, ending balance (in shares) at Jun. 30, 2023 | 139,705 | 139,854 | |||||
Equity, ending balance at Jun. 30, 2023 | $ 632,889 | $ 139,854 | 777,813 | (45,049) | (1,041) | (241,062) | 2,374 |
Shares outstanding, beginning balance (in shares) at Mar. 31, 2023 | 139,854 | ||||||
Equity, beginning balance at Mar. 31, 2023 | 674,973 | $ 139,854 | 774,069 | (24,624) | (1,041) | (215,780) | 2,495 |
Share-based compensation expense | 3,688 | 3,688 | |||||
Net (loss) income | (25,403) | (25,282) | (121) | ||||
Reclassification of warrants from liability classified to equity classified | 56 | 56 | |||||
Other comprehensive income (loss) | $ (20,425) | (20,425) | |||||
Shares outstanding, ending balance (in shares) at Jun. 30, 2023 | 139,705 | 139,854 | |||||
Equity, ending balance at Jun. 30, 2023 | $ 632,889 | $ 139,854 | $ 777,813 | $ (45,049) | $ (1,041) | $ (241,062) | $ 2,374 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (38,306) | $ (30,236) |
Adjustments to reconcile net loss to cash used in operating activities: | ||
Share-based compensation expense | 5,201 | 2,923 |
Depreciation and amortization | 732 | 186 |
Reduction in the carrying amount of right-of-use assets | 491 | 746 |
Warrant liability fair value adjustment | 1,151 | (24,704) |
Convertible note fair value adjustment | (1,074) | (491) |
Share of net loss of equity method investee | 55 | 463 |
Foreign currency transaction net unrealized gain | (23,247) | (2,113) |
Other | 145 | 0 |
Changes in assets and liabilities: | ||
Prepaid assets and other current assets | 2,834 | (12,663) |
Accounts payable, accrued liabilities and other | 19,967 | 15,902 |
Operating lease liability | (2,669) | (443) |
Net cash used in operating activities | (34,720) | (50,430) |
Cash flows from investing activities: | ||
Proceeds from property related grants | 0 | 4,874 |
Purchases of property and equipment | (128,361) | (26,420) |
Investments in equity method investee | (1,655) | (3,000) |
Purchases of other long-term assets | (1,000) | 0 |
Net cash used in investing activities | (131,016) | (24,546) |
Cash flows from financing activities: | ||
Repurchase of treasury shares | 0 | (1,052) |
Net cash used in financing activities | 0 | (1,052) |
Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | (13,520) | (1,235) |
Net decrease in cash, cash equivalents, and restricted cash | (179,256) | (77,263) |
Cash, cash equivalents, and restricted cash at beginning of period | 563,045 | 565,627 |
Cash, cash equivalents, and restricted cash at end of period | 383,789 | 488,364 |
Significant non-cash investing and financing activities: | ||
Accrued purchases of property and equipment | 23,085 | 13,026 |
Reconciliation to condensed consolidated balance sheets: | ||
Cash and cash equivalents | 334,364 | 484,204 |
Restricted cash | 49,425 | 4,160 |
Cash, cash equivalents, and restricted cash | $ 383,789 | $ 488,364 |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of the Business FREYR Battery (“FREYR,” the “Company”, “we”, or “us”) is a developer of clean, next-generation battery cell production capacity. Our mission and vision are to accelerate the decarbonization of global energy and transportation systems by producing clean, cost-competitive batteries. Through our strategy of Speed, Scale, and Sustainability, we seek to serve our primary markets of energy storage systems (“ESS”), commercial mobility, including marine applications and commercial vehicles; and electric vehicles (“EV”). We have put into service the buildings and infrastructure and certain manufacturing equipment at our Customer Qualification Plant (“CQP”), and have successfully completed semi-automatic production, assembly, and charge of our first battery. We will spend the next several months increasing the amount of integration and automation of the manufacturing process and anticipate producing sample cells for customers during the third quarter of this year. We have begun the construction of initial buildings and infrastructure for our inaugural gigafactory (“Giga Arctic”). Both the CQP and Giga Arctic are located in Mo i Rana, Norway. We have also started the development of our first clean battery cell manufacturing project in the U.S. (“Giga America”), which is located on a 368-acre parcel of land in Coweta County, Georgia that was purchased by the Company in 2022. As of June 30, 2023, we have not yet initiated commercial manufacturing or derived revenue from our principal business activities. Basis of Presentation The unaudited condensed consolidated interim financial statements have been prepared in conformity with the accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission (“SEC”) Regulation S-X. Accordingly, these financial statements do not include all of the information required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated interim financial statements have been prepared on the same basis as the audited annual consolidated financial statements for the year ended December 31, 2022 and, in management’s opinion, include all adjustments, consisting of only normal recurring adjustments necessary for the fair presentation of the Company’s condensed consolidated financial statements for the periods presented. The results of operations for the six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023. The condensed consolidated balance sheet as of December 31, 2022, was derived from the audited consolidated financial statements as of December 31, 2022. However, these condensed consolidated interim financial statements do not contain all of the footnote disclosures from the annual consolidated financial statements. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 27, 2023. The condensed consolidated financial statements include the accounts of FREYR, its wholly owned subsidiaries, majority-owned subsidiaries, and variable interest entities (“VIE”) of which we are the primary beneficiary. Certain prior period balances and amounts have been reclassified to conform with the current year’s presentation. Use of Estimates The preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Estimates and assumptions include, but are not limited to, estimates related to the valuation of warrant liability, share-based compensation, and the convertible note. We base these estimates on historical experiences and on various other assumptions that we believe are reasonable under the circumstances, however, actual results may differ materially from these estimates. Risks and Uncertainties We are subject to those risks common to our business and industry and also those risks common to early stage development companies. These risks include those disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 27, 2023. T hese financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that we will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. As of the date of this report, our existing cash resources, which were primarily provided as a result of our business combination with Alussa Energy Acquisition Corporation in 2021 and issuance of equity securities, are sufficient to support our planned operations for at least the next 12 months from the date of issuance of these financial statements. Therefore, our financial statements have been prepared on the basis that we will continue as a going concern. Restricted Cash Certain cash balances are restricted as to withdrawal or use. Restricted cash primarily consists of the balance of an account held for the construction of Giga Arctic. Additionally, restricted cash includes funds held in a restricted account for the payment of upfront rental lease deposits and government income tax withholdings. Significant Accounting Policies The Company’s significant accounting policies were included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Supplemental accounting policy disclosures are included above. |
PROPERTY AND EQUIPMENT, NET AND
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET | 6 Months Ended |
Jun. 30, 2023 | |
Property, Plant And Equipment And Intangible Assets [Abstract] | |
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET | PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET Property and Equipment, net Property and equipment, net consisted of the following (in thousands): June 30, December 31, Land $ 44,326 $ 44,326 Leasehold improvements 26,106 21 Machinery and equipment 4,944 61 Office equipment 2,546 2,532 Construction in progress 243,229 164,387 321,151 211,327 Less: Accumulated depreciation (1,144) (550) Total $ 320,007 $ 210,777 Land consists of a 368-acre parcel of land in Coweta County, Georgia, which was purchased in 2022 for the development of Giga America. Leasehold improvements and machinery and equipment as of June 30, 2023 are largely related to the Company’s CQP in Mo i Rana, Norway. Construction in progress primarily includes costs related to the construction of the Giga Arctic facilities and production equipment for the CQP and Giga Arctic in Mo i Rana, Norway. Depreciation expense was $0.5 million and $0.1 million for the three months ended June 30, 2023 and 2022, respectively, and $0.7 million and $0.2 million for the six months ended June 30, 2023 and 2022, respectively. Intangible Assets, net Intangible assets, net consisted of the following (in thousands): As of June 30, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net License $ 3,000 $ (112) $ 2,888 $ 3,000 $ (37) $ 2,963 Intangible assets consist of a license to produce and sell lithium-iron phosphate cathode battery materials using Taiwan based Advanced Lithium Electrochemistry Co., Ltd. ’s technology. The license has a 20-year useful life. Amortization expense was $37,000 and $75,000 for the three and six months ended June 30, 2023, respectively, (no comparative amounts for the three and six months ended June 30, 2022). Future annual amortization expense is estimated to be $150,000 for the full year 2023 and each of the next four years. |
LONG-TERM INVESTMENTS
LONG-TERM INVESTMENTS | 6 Months Ended |
Jun. 30, 2023 | |
Long-Term Investments [Abstract] | |
LONG-TERM INVESTMENTS | LONG-TERM INVESTMENTS The Company’s equity investments consisted of the following (in thousands): June 30, December 31, Investment Equity method investments: Nidec Energy AS $ 1,600 $ — Investments without readily determinable fair values: 24M preferred stock 21,028 — Total Long-Term Investments $ 22,628 $ — Equity Method Investments In March 2023, the Company contributed $1.7 million to obtain a 33% equity interest in Nidec Energy AS (the “Nidec JV”), a joint venture with Nidec Europe BV (“Nidec”). The Nidec JV was formed to develop, manufacture, and sell battery modules and battery packs for industrial and utility-grade ESS applications. The Company determined that the Nidec JV was a VIE, and that the Company was not the primary beneficiary. Additionally, the Company is able to exercise significant influence but not control over the operating and financial policies of the Nidec JV. Therefore, the Company has recorded its investment in the Nidec JV as an equity method investment. In October 2021, we formed a joint venture, with the purpose of advancing the development of clean battery cell manufacturing in the U.S. (the “U.S. JV”). At the time of this initial investment, the Company agreed to contribute $3.0 million for the initial costs related to developing the first gigafactory to project concept selection, and this contribution was made in January 2022. We held a 50% common stock ownership in the U.S. JV and utilized the equity method of accounting for the U.S. JV through October 2022. In November 2022, the Company contributed an additional $49.0 million to the U.S. JV, increasing the Company’s common share ownership in the U.S. JV to 95%. The Company reevaluated its classification of the U.S. JV, which was determined to meet the characteristics of a VIE. The Company was deemed to be the primary beneficiary of the U.S. JV and began consolidating the U.S. JV in November 2022. During the six months ended June 30, 2023, the Company made an additional $22.6 million contribution and increased its common share ownership to 96%. The Company recognized its share of net loss of equity method investee in the condensed consolidated statements of operations and comprehensive loss of $0.1 million related to the Company’s equity method investment in the Nidec JV and $0.5 million related to the Company’s equity method investment in the U.S. JV, for the six months ended June 30, 2023 and 2022, respectively. Equity Investments Without Readily Determinable Fair Values On October 8, 2021, we invested in an unsecured convertible note receivable (the “Convertible Note”) from 24M Technologies, Inc. (“24M”), our battery platform technology licensor for our planned manufacturing facilities in Norway and the U.S. In December 2022, we signed a contract amendment that would result in the Convertible Note converting to preferred stock in March 2023 based on the contractual conversion price in the original contract. On March 24, 2023, we converted the Convertible Note to preferred stock of 24M. See Note 7 – Fair Value Measurement for further details. The 24M preferred stock does not have a readily determinable fair value and does not provide the Company with control or significant influence. Therefore, the Company has elected to account for the 24M preferred stock under the measurement alternative, defined as cost, less impairment, adjusted for subsequent observable price changes. We assess relevant transactions that occur on or before the balance sheet date to identify observable price changes, and we regularly monitor these investments to evaluate whether there is an indication that the investment is impaired. |
ACCRUED LIABILITIES AND OTHER
ACCRUED LIABILITIES AND OTHER | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
ACCRUED LIABILITIES AND OTHER | ACCRUED LIABILITIES AND OTHER Accrued liabilities and other consisted of the following (in thousands): June 30, December 31, Accrued purchases $ 14,997 $ 34,932 Accrued payroll and payroll related expenses 14,043 12,936 Operating lease liabilities 3,237 3,257 Accrued other operating costs 233 321 Total $ 32,510 $ 51,446 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Legal Proceedings From time to time, we may be subject to legal and regulatory actions that arise in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events. Management believes that any liability that may arise out of or with respect to these matters will not materially, adversely affect our condensed consolidated financial position, results of operations, or liquidity. |
WARRANTS
WARRANTS | 6 Months Ended |
Jun. 30, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
WARRANTS | WARRANTS Public and Private Warrants As of June 30, 2023 and December 31, 2022, we had 24.6 million warrants outstanding (the “Warrants”), consisting of 14.6 million public warrants (the “Public Warrants”) and 10.0 million private warrants (the “Private Warrants”). The Warrants entitle the holder thereof to purchase one of our ordinary shares at a price of $11.50 per share, subject to adjustments. The Warrants will expire on July 9, 2026, or earlier upon redemption or liquidation. We may call the Public Warrants for redemption once they become exercisable, in whole and not in part, at a price of $0.01 per Public Warrant, so long as we provide at least 30 days prior written notice of redemption to each Public Warrant holder, and if, and only if, the reported last sales price of our ordinary shares equals or exceeds $18.00 per share for each of 20 trading days within the 30 trading-day period ending on the third trading day before the date on which we send the notice of redemption to the Public Warrant holders. We determined that the Public Warrants are equity classified as they are indexed to our ordinary shares and qualify for classification within shareholders’ equity. As such, the Public Warrants are presented as part of additional paid-in capital on the condensed consolidated balance sheets. The Private Warrants are identical to the Public Warrants, except that so long as they are held by a certain holder or any of its permitted transferees, the Private Warrants: (i) may be exercised for cash or on a cashless basis and (ii) shall not be redeemable by FREYR. We determined that the Private Warrants are not considered indexed to our ordinary shares as the holder of the Private Warrants impacts the settlement amount and therefore, they are liability classified. The Private Warrants are presented as warrant liability on the condensed consolidated balance sheets. If Private Warrants are sold or transferred to another party that is not the specified holder or any of its permitted transferees, the Private Warrants become Public Warrants and qualify for classification within shareholders’ equity at the fair value on the date of the transfer. See also Note 7 – Fair Value Measurement. EDGE Warrants As of June 30, 2023 and December 31, 2022, we had 2.2 million EDGE warrants outstanding and exercisable, which entitle the holder thereof to purchase one of our ordinary shares at the exercise price, subject to adjustments. The EDGE warrants consist of 1.5 million warrants with an exercise price of $0.95 which expire on May 15, 2024 and 0.7 million warrants with an exercise price of $1.22, which expire on September 30, 2025. We determined that the EDGE warrants are equity classified as they are indexed to our ordinary shares. |
FAIR VALUE MEASUREMENT
FAIR VALUE MEASUREMENT | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENT | FAIR VALUE MEASUREMENT The following table sets forth, by level within the fair value hierarchy, the accounting of our financial assets and liabilities at fair value on a recurring basis according to the valuation techniques we use to determine their fair value (in thousands): June 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Convertible Note $ — $ — $ — $ — $ — $ — $ 19,954 $ 19,954 Liabilities: Warrant Liabilities $ — $ — $ 34,939 $ 34,939 $ — $ — $ 33,849 $ 33,849 We measured our Private Warrants and the Convertible Note at fair value based on significant inputs not observable in the market, which caused them to be classified as Level 3 measurements within the fair value hierarchy. These valuations used assumptions and estimates that we believed a market participant would use in making the same valuation. Changes in the fair value of the Private Warrants were recognized as a warrant liability fair value adjustment within the condensed consolidated statements of operations and comprehensive loss. Changes in the fair value of the Convertible Note were recognized as a convertible note fair value adjustment within the condensed consolidated statement of operations and comprehensive loss. As of June 30, 2023 and December 31, 2022, the carrying value of all other financial assets and liabilities approximated their respective fair values. Private Warrants The Private Warrants outstanding on June 30, 2023 and December 31, 2022, were valued using the Black-Scholes-Merton option pricing model. See Note 6 – Warrants above for further detail. Our use of the Black-Scholes-Merton option pricing model for the Private Warrants required the use of subjective assumptions, including: • The risk-free interest rate assumption was based on the U.S. Treasury Rates commensurate with the contractual terms of the Private Warrants. • The expected term was determined based on the expiration date of the Private Warrants. • The expected volatility assumption was based on the implied volatility from a set of comparable publicly traded companies as determined based on the size and industry. An increase in each of the risk-free interest rate, expected term, or expected volatility, in isolation, would increase the fair value measurement, and a decrease in each of these assumptions would decrease the fair value measurement, of the Private Warrants. Using this approach, an exercise price of $11.50 and a share price of $9.35 and $8.68 as of June 30, 2023 and December 31, 2022, respectively, we determined that the fair value of the Private Warrants was $34.9 million and $33.8 million, respectively. Convertible Note On October 8, 2021, we invested $20.0 million in the Convertible Note and elected to account for the Convertible Note using the fair value option. The Convertible Note was scheduled to mature on October 8, 2024, carried an annual interest rate of 5%, and was convertible into common stock or preferred stock at our option beginning on October 8, 2023 or automatically upon certain events. In December 2022, we signed a contract amendment that would result in the Convertible Note converting to preferred stock in March 2023, based on the contractual conversion price in the original contract. We determined the fair value of the Convertible Note, prior to its conversion to preferred stock of 24M. See Note 3 – Long-Term Investments for further details. The Convertible Note was valued using a scenario-based framework, where the fair values determined in various scenarios were weighted based on the estimated probability of occurrence. Within each scenario, a discounted cash flow approach was utilized, taking the expected payoff for the event, and discounting it based on the expected timing and a discount rate. Each of the assumptions in this model were considered significant assumptions. Rollforward of Level 3 Fair Value The changes in the Level 3 instruments measured at fair value on a recurring basis were as follows (in thousands): For the six months ended Asset Liability Convertible Note Private Warrants Balance (beginning of period) $ 19,954 $ 33,849 Fair value measurement adjustments 1,074 1,151 Conversion to preferred stock (21,028) — Reclassification to Public Warrants — (61) Balance (end of period) $ — $ 34,939 |
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY | 6 Months Ended |
Jun. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
SHAREHOLDERS’ EQUITY | SHAREHOLDERS' EQUITY Ordinary Shares As of both June 30, 2023 and December 31, 2022, 245.0 million ordinary shares without par value were authorized and 139.7 million were outstanding. On issuance of shares, amounts designated by our Board of Directors as share capital are included as ordinary share capital and any remaining proceeds are shown as additional paid-in capital in our condensed consolidated balance sheets. Holders of ordinary shares are entitled to one vote per share and to receive dividends when, as, and if, declared by our Board of Directors. As of June 30, 2023, we have not declared any dividends. In December 2022, FREYR closed a public offering of 23.0 million ordinary shares at an offering price of $11.50 per share for total gross proceeds of approximately $264.5 million. Share Repurchase Program In May 2022, the Board of Directors approved a share repurchase program (the “Share Repurchase Program”) . The shares purchased under the program are to be used to settle the exercise of employee options granted under the Company’s equity compensation plans. We were authorized to repurchase up to 150,000 of the Company’s ordinary shares. The Share Repurchase Program had no time limit and was able to be suspended or discontinued at any time. We purchased 150,000 ordinary shares at an average price of $6.97 per share, excluding fees, during the three and six months ended June 30, 2022. No purchases were made during the three and six months ended June 30, 2023 . As of June 30, 2023, the authorized share repurchase was completed and no ordinary shares remain available for repurchase under the program. Share-Based Compensation 2021 Plan In June 2021, we adopted the 2021 Equity Incentive Plan (the “2021 Plan”), which was amended and restated in June 2023. The 2021 Plan provides for the grant of stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights, performance units, and performance shares to our employees, directors, and consultants. Generally, our stock options and RSUs vest annually over three years and our stock options are exercisable over a maximum period of five years from their grant dates. Options are typically forfeited when the employment relationship ends for employees and they do not typically forfeit for directors. Generally, our RSUs are liability-classified awards, as they are cash settled based on the closing price of the shares on the vesting date. All exercised options are expected to be settled in shares, net of shares withheld to satisfy the award exercise price and related taxes. As of June 30, 2023, a total of 25.0 million shares were authorized for issuance to satisfy share-based compensation awards made under the 2021 Plan. During the six months ended June 30, 2023, 3.5 million options were granted to employees and directors, 116,000 RSUs were granted, 124,000 options were forfeited, and 20,000 RSUs vested and were cash settled. 2019 Plan FREYR Legacy had an Incentive Stock Option Plan (the “2019 Plan”) issued on September 11, 2019. All stock options and warrants granted under the 2019 Plan are fully vested and no further awards can be issued. Certain of the outstanding awards under the 2019 Plan were required to be cash settled as of June 30, 2023, and the remaining awards were required to be cash settled as of July 9, 2023. The awards granted under the 2019 Plan are liability-classified awards, and as such, these awards are remeasured to fair value at each reporting date with changes to the fair value recognized as stock compensation expense in general and administrative expense or research and development expense within the condensed consolidated statements of operations and comprehensive loss. Cumulative stock compensation expense cannot be reduced below the grant date fair value of the original award. During the six months ended June 30, 2023, 9,000 of the 201 9 Plan awards were exercised. CEO Option Awards |
GOVERNMENT GRANTS
GOVERNMENT GRANTS | 6 Months Ended |
Jun. 30, 2023 | |
Government Assistance [Abstract] | |
GOVERNMENT GRANTS | GOVERNMENT GRANTS For both the three and six months ended June 30, 2023 we recognized grant income of $0.1 million in other income, net within the condensed consolidated statements of operations and comprehensive loss. For the three and six months ended June 30, 2022 we recognized grant income of $0.6 million and $2.0 million, respectively, in other income, net within the condensed consolidated statements of operations and comprehensive loss. For the six months ended June 30, 2022, we recorded grant income of $4.9 million, as a reduction of property and equipment, net on our condensed consolidated balance sheets, as these grants partially offset capitalized costs related to the construction in progress for the CQP. There was no grant income recorded as a reduction of property and equipment, net for the other periods presented. As of both June 30, 2023 and December 31, 2022, we had $0.2 million in short-term deferred income from grants recorded in accrued liabilities and other on our condensed consolidated balance sheets. As of June 30, 2023 and December 31, 2022, we had $20.0 million and zero, respectively, in long-term deferred income from grants recorded in other long-term liabilities on our condensed consolidated balance sheets. Significant Grant Awards |
INCOME TAXES
INCOME TAXES | 6 Months Ended |
Jun. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES The provision for income taxes is recorded at the end of each interim period based on the Company’s best estimate of its effective income tax rate expected to be applicable for the full fiscal year. The Company has incurred taxable losses in each year since inception, and maintains a full valuation allowance against its loss carryforwards and other deferred tax assets. The Company and certain of its operating subsidiaries generate taxable income in certain jurisdictions or taxable foreign company U.S. sourced income. The Company’s effective income tax rate was 1% for both the three and six months ended June 30, 2023 and 0% for both the three and six months ended June 30, 2022. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Consulting Agreement In May 2021, we entered into a consulting agreement with a member of the Board of Directors. Per this agreement, the consultant will provide services for a term of three years. During this term, we will pay the consultant a monthly fee of $30,000 plus related reimbursable costs. The total expenses incurred for these consulting services for the three and six months ended June 30, 2023 were $0.1 million and $0.2 million, respectively. The expenses incurred for consulting services for the three and six months ended June 30, 2022 were $0.2 million and $0.3 million, respectively. These expenses are recognized as general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss. As of both June 30, 2023 and December 31, 2022, an unpaid amount of $0.1 million is recorded in accrued liabilities and other. Metier |
NET (LOSS) INCOME PER SHARE
NET (LOSS) INCOME PER SHARE | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
NET (LOSS) INCOME PER SHARE | NET (LOSS) INCOME PER SHARE The Company’s basic net (loss) income per share attributable to ordinary shareholders was computed by dividing net (loss) income attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding. Diluted net (loss) income per share attributable to ordinary shareholders adjusts basic net (loss) income per share attributable to ordinary shareholders to give effect to all potential ordinary shares that were dilutive and outstanding during the period. The treasury stock method was used to assess our warrants and share-based payment awards. The computation of basic and diluted net (loss) income attributable to ordinary shareholders per share is as follows (in thousands, except per share data): Three months ended Six months ended 2023 2022 2023 2022 Numerator: Net (loss) income attributable to ordinary shareholders - basic and diluted $ (25,282) $ 4,671 $ (38,008) $ (30,236) Denominator: Weighted average ordinary shares outstanding – basic 139,705 116,830 139,705 116,842 Dilutive effect of EDGE Warrants and share-based compensation liability awards — 2,420 — — Weighted average ordinary shares outstanding – dilutive 139,705 119,250 139,705 116,842 Net (loss) income attributable to ordinary shareholders per share: Basic $ (0.18) $ 0.04 $ (0.27) $ (0.26) Diluted $ (0.18) $ 0.04 $ (0.27) $ (0.26) The outstanding securities that could potentially dilute basic net (loss) income attributable to ordinary shareholders per share in the future that were not included in the computation of diluted net (loss) income attributable to ordinary shareholders per share as the impact would be anti-dilutive are as follows (in thousands): Three months ended Six months ended 2023 2022 2023 2022 Public Warrants 14,625 14,375 14,625 14,375 Private Warrants 10,000 10,250 10,000 10,250 EDGE warrants 2,176 — 2,176 2,176 Employee awards 9,240 4,881 9,240 4,881 Share-based compensation liability awards (1) 567 — 567 784 CEO option awards (2) 661 94 661 94 Total 37,269 29,600 37,269 32,560 (1) For the three and six months ended June 30, 2023, the Company excluded 101,000 of the total outstanding 668,000 share-based compensation liability awards, as these awards are required to be cash-settled. See Note 8 – Shareholders' Equity for further details. (2) For the three and six months ended June 30, 2022, the Company excluded 756,000 of the total 850,000 CEO option awards, as it was not yet probable that the performance conditions for these options would be achieved. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The unaudited condensed consolidated interim financial statements have been prepared in conformity with the accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission (“SEC”) Regulation S-X. Accordingly, these financial statements do not include all of the information required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated interim financial statements have been prepared on the same basis as the audited annual consolidated financial statements for the year ended December 31, 2022 and, in management’s opinion, include all adjustments, consisting of only normal recurring adjustments necessary for the fair presentation of the Company’s condensed consolidated financial statements for the periods presented. The results of operations for the six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023. The condensed consolidated balance sheet as of December 31, 2022, was derived from the audited consolidated financial statements as of December 31, 2022. However, these condensed consolidated interim financial statements do not contain all of the footnote disclosures from the annual consolidated financial statements. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on February 27, 2023. The condensed consolidated financial statements include the accounts of FREYR, its wholly owned subsidiaries, majority-owned subsidiaries, and variable interest entities (“VIE”) of which we are the primary beneficiary. Certain prior period balances and amounts have been reclassified to conform with the current year’s presentation. |
Use of Estimates | Use of EstimatesThe preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Estimates and assumptions include, but are not limited to, estimates related to the valuation of warrant liability, share-based compensation, and the convertible note. We base these estimates on historical experiences and on various other assumptions that we believe are reasonable under the circumstances, however, actual results may differ materially from these estimates. |
Restricted Cash | Restricted Cash Certain cash balances are restricted as to withdrawal or use. Restricted cash primarily consists of the balance of an account held for the construction of Giga Arctic. Additionally, restricted cash includes funds held in a restricted account for the payment of upfront rental lease deposits and government income tax withholdings. |
PROPERTY AND EQUIPMENT, NET A_2
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Property, Plant And Equipment And Intangible Assets [Abstract] | |
Schedule of Property and Equipment | Property and equipment, net consisted of the following (in thousands): June 30, December 31, Land $ 44,326 $ 44,326 Leasehold improvements 26,106 21 Machinery and equipment 4,944 61 Office equipment 2,546 2,532 Construction in progress 243,229 164,387 321,151 211,327 Less: Accumulated depreciation (1,144) (550) Total $ 320,007 $ 210,777 |
Schedule of Intangible Assets | Intangible assets, net consisted of the following (in thousands): As of June 30, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net License $ 3,000 $ (112) $ 2,888 $ 3,000 $ (37) $ 2,963 |
LONG-TERM INVESTMENTS (Tables)
LONG-TERM INVESTMENTS (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Long-Term Investments [Abstract] | |
Schedule of Equity Investments | The Company’s equity investments consisted of the following (in thousands): June 30, December 31, Investment Equity method investments: Nidec Energy AS $ 1,600 $ — Investments without readily determinable fair values: 24M preferred stock 21,028 — Total Long-Term Investments $ 22,628 $ — |
ACCRUED LIABILITIES AND OTHER (
ACCRUED LIABILITIES AND OTHER (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Liabilities and Other | Accrued liabilities and other consisted of the following (in thousands): June 30, December 31, Accrued purchases $ 14,997 $ 34,932 Accrued payroll and payroll related expenses 14,043 12,936 Operating lease liabilities 3,237 3,257 Accrued other operating costs 233 321 Total $ 32,510 $ 51,446 |
FAIR VALUE MEASUREMENT (Tables)
FAIR VALUE MEASUREMENT (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Financial Assets and Liabilities at Fair Value on a Recurring Basis | The following table sets forth, by level within the fair value hierarchy, the accounting of our financial assets and liabilities at fair value on a recurring basis according to the valuation techniques we use to determine their fair value (in thousands): June 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Convertible Note $ — $ — $ — $ — $ — $ — $ 19,954 $ 19,954 Liabilities: Warrant Liabilities $ — $ — $ 34,939 $ 34,939 $ — $ — $ 33,849 $ 33,849 |
Schedule of Changes in the Level 3 Assets Measured at Fair Value | The changes in the Level 3 instruments measured at fair value on a recurring basis were as follows (in thousands): For the six months ended Asset Liability Convertible Note Private Warrants Balance (beginning of period) $ 19,954 $ 33,849 Fair value measurement adjustments 1,074 1,151 Conversion to preferred stock (21,028) — Reclassification to Public Warrants — (61) Balance (end of period) $ — $ 34,939 |
Schedule of Changes in the Level 3 Liabilities Measured at Fair Value | The changes in the Level 3 instruments measured at fair value on a recurring basis were as follows (in thousands): For the six months ended Asset Liability Convertible Note Private Warrants Balance (beginning of period) $ 19,954 $ 33,849 Fair value measurement adjustments 1,074 1,151 Conversion to preferred stock (21,028) — Reclassification to Public Warrants — (61) Balance (end of period) $ — $ 34,939 |
NET (LOSS) INCOME PER SHARE (Ta
NET (LOSS) INCOME PER SHARE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Net Loss per Share Attributable to Ordinary Shareholders | Three months ended Six months ended 2023 2022 2023 2022 Numerator: Net (loss) income attributable to ordinary shareholders - basic and diluted $ (25,282) $ 4,671 $ (38,008) $ (30,236) Denominator: Weighted average ordinary shares outstanding – basic 139,705 116,830 139,705 116,842 Dilutive effect of EDGE Warrants and share-based compensation liability awards — 2,420 — — Weighted average ordinary shares outstanding – dilutive 139,705 119,250 139,705 116,842 Net (loss) income attributable to ordinary shareholders per share: Basic $ (0.18) $ 0.04 $ (0.27) $ (0.26) Diluted $ (0.18) $ 0.04 $ (0.27) $ (0.26) |
Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share | The outstanding securities that could potentially dilute basic net (loss) income attributable to ordinary shareholders per share in the future that were not included in the computation of diluted net (loss) income attributable to ordinary shareholders per share as the impact would be anti-dilutive are as follows (in thousands): Three months ended Six months ended 2023 2022 2023 2022 Public Warrants 14,625 14,375 14,625 14,375 Private Warrants 10,000 10,250 10,000 10,250 EDGE warrants 2,176 — 2,176 2,176 Employee awards 9,240 4,881 9,240 4,881 Share-based compensation liability awards (1) 567 — 567 784 CEO option awards (2) 661 94 661 94 Total 37,269 29,600 37,269 32,560 (1) For the three and six months ended June 30, 2023, the Company excluded 101,000 of the total outstanding 668,000 share-based compensation liability awards, as these awards are required to be cash-settled. See Note 8 – Shareholders' Equity for further details. (2) For the three and six months ended June 30, 2022, the Company excluded 756,000 of the total 850,000 CEO option awards, as it was not yet probable that the performance conditions for these options would be achieved. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) | Jun. 30, 2023 a |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Area of Land | 368 |
PROPERTY AND EQUIPMENT, NET A_3
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Property, Plant And Equipment And Intangible Assets [Abstract] | ||
Land | $ 44,326 | $ 44,326 |
Leasehold improvements | 26,106 | 21 |
Machinery and equipment | 4,944 | 61 |
Office equipment | 243,229 | 164,387 |
Construction in progress | 2,546 | 2,532 |
Property and equipment, gross | 321,151 | 211,327 |
Less: Accumulated depreciation | (1,144) | (550) |
Total | $ 320,007 | $ 210,777 |
PROPERTY AND EQUIPMENT, NET A_4
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET - Narrative (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 USD ($) a | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) a | Jun. 30, 2022 USD ($) | |
Finite-Lived Intangible Assets [Line Items] | ||||
Area of Land | a | 368 | 368 | ||
Depreciation expense | $ 500 | $ 100 | $ 700 | $ 200 |
Amortization of intangible assets | 37 | $ 0 | 75 | $ 0 |
Intangible asset, expected amortization, year one | 150 | 150 | ||
Intangible asset, expected amortization, year two | 150 | 150 | ||
Intangible asset, expected amortization, year three | 150 | 150 | ||
Intangible asset, expected amortization, year four | 150 | 150 | ||
Intangible asset, expected amortization, year five | $ 150 | $ 150 | ||
License | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Intangible asset, estimated useful life | 20 years | 20 years |
PROPERTY AND EQUIPMENT, NET A_5
PROPERTY AND EQUIPMENT, NET AND INTANGIBLE ASSETS, NET - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Net Carrying Amount | $ 2,888 | $ 2,963 |
License | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 3,000 | 3,000 |
Accumulated Amortization | (112) | (37) |
Net Carrying Amount | $ 2,888 | $ 2,963 |
LONG-TERM INVESTMENTS - Schedul
LONG-TERM INVESTMENTS - Schedule Of Equity Investments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Equity method investments: | ||
Nidec Energy AS | $ 1,600 | $ 0 |
Investments without readily determinable fair values: | ||
24M preferred stock | 21,028 | 0 |
Total Long-Term Investments | $ 22,628 | $ 0 |
LONG-TERM INVESTMENTS - Narrati
LONG-TERM INVESTMENTS - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||||
Nov. 07, 2022 | Mar. 31, 2023 | Oct. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Oct. 31, 2022 | |
Schedule of Equity Method Investments [Line Items] | ||||||||
Equity method investment, contributions | $ 1,655 | $ 3,000 | ||||||
Share of net loss of equity method investee | $ 30 | $ 296 | 55 | 463 | ||||
Nidec Energy AS | ||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||
Equity method investment, contributions | $ 1,700 | |||||||
Equity method investment, ownership percentage | 33% | |||||||
Share of net loss of equity method investee | 100 | |||||||
Freyr Battery US, LLC | ||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||
Equity method investment, contributions | $ 49,000 | $ 3,000 | $ 22,600 | |||||
Equity method investment, ownership percentage | 95% | 96% | 96% | 50% | ||||
Share of net loss of equity method investee | $ 500 |
ACCRUED LIABILITIES AND OTHER_2
ACCRUED LIABILITIES AND OTHER (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Payables and Accruals [Abstract] | ||
Accrued purchases | $ 14,997 | $ 34,932 |
Accrued payroll and payroll related expenses | $ 14,043 | 12,936 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Total | |
Operating lease liabilities | $ 3,237 | 3,257 |
Accrued other operating costs | 233 | 321 |
Total | $ 32,510 | $ 51,446 |
WARRANTS (Details)
WARRANTS (Details) - $ / shares | 6 Months Ended | |||
Sep. 25, 2020 | Mar. 01, 2019 | Jun. 30, 2023 | Dec. 31, 2022 | |
Class of Warrant or Right [Line Items] | ||||
Warrant outstanding (in shares) | 24,600,000 | 24,600,000 | ||
Warrant, number of shares called by each warrant (in shares) | 1 | |||
Warrant, exercice price (in USD per share) | $ 11.50 | |||
EDGE warrants | Non-employee | ||||
Class of Warrant or Right [Line Items] | ||||
Awards outstanding (in shares) | 2,200,000 | 2,200,000 | ||
Awards exercisable (in shares) | 2,200,000 | 2,200,000 | ||
Warrant, awards issued (in shares) | 700,000 | 1,500,000 | ||
Warrant, exercise price (in USD per share) | $ 1.22 | $ 0.95 | ||
Public warrants | ||||
Class of Warrant or Right [Line Items] | ||||
Warrant outstanding (in shares) | 14,600,000 | 14,600,000 | ||
Warrant, redemption price (in USD per share) | $ 0.01 | |||
Warrant, minimum prior written notice | 30 days | |||
Warrant, redemption, price trigger (in USD per share) | $ 18 | |||
Warrant, threshold trading days | 20 days | |||
Warrant, threshold consecutive trading days | 30 days | |||
Private warrants | ||||
Class of Warrant or Right [Line Items] | ||||
Warrant outstanding (in shares) | 10,000,000 | 10,000,000 |
FAIR VALUE MEASUREMENT - Schedu
FAIR VALUE MEASUREMENT - Schedule of Financial Assets and Liabilities at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Warrant Liabilities | ||
Liabilities: | ||
Warrant Liabilities | $ 34,939 | $ 33,849 |
Convertible Note | ||
Assets: | ||
Convertible Note | 0 | 19,954 |
Level 1 | Warrant Liabilities | ||
Liabilities: | ||
Warrant Liabilities | 0 | 0 |
Level 1 | Convertible Note | ||
Assets: | ||
Convertible Note | 0 | 0 |
Level 2 | Warrant Liabilities | ||
Liabilities: | ||
Warrant Liabilities | 0 | 0 |
Level 2 | Convertible Note | ||
Assets: | ||
Convertible Note | 0 | 0 |
Level 3 | Warrant Liabilities | ||
Liabilities: | ||
Warrant Liabilities | 34,939 | 33,849 |
Level 3 | Convertible Note | ||
Assets: | ||
Convertible Note | $ 0 | $ 19,954 |
FAIR VALUE MEASUREMENT - Narrat
FAIR VALUE MEASUREMENT - Narrative (Details) $ in Thousands | Jun. 30, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Oct. 08, 2021 USD ($) |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Warrant liability | $ 34,939 | $ 33,849 | |
Convertible note | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Investment, face amount | $ 20,000 | ||
Investment, annual interest rate | 5% | ||
Private warrants | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Warrant liability | $ 34,900 | $ 33,800 | |
Private warrants | Measurement input, exercise price | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Warrants, measurement input (in USD per share) | $ / shares | 11.50 | 11.50 | |
Private warrants | Measurement input, share price | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Warrants, measurement input (in USD per share) | $ / shares | 9.35 | 8.68 |
FAIR VALUE MEASUREMENT - Sche_2
FAIR VALUE MEASUREMENT - Schedule of Changes in the Level 3 Assets and Liabilities Measured at Fair Value (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Warrant Liabilities | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance (beginning of period) | $ 33,849 |
Fair value measurement adjustments | 1,151 |
Conversion to preferred stock | 0 |
Reclassification to Public Warrants | (61) |
Balance (end of period) | 34,939 |
Convertible Note | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance (beginning of period) | 19,954 |
Fair value measurement adjustments | 1,074 |
Conversion to preferred stock | (21,028) |
Reclassification to Public Warrants | 0 |
Balance (end of period) | $ 0 |
SHAREHOLDERS' EQUITY (Details)
SHAREHOLDERS' EQUITY (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
Jul. 13, 2021 criteria $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Jun. 30, 2023 vote criteria shares | Jun. 30, 2022 $ / shares shares | Jun. 30, 2023 USD ($) vote criteria shares | Jun. 30, 2022 $ / shares shares | May 31, 2022 shares | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Ordinary share capital, shares authorized (in shares) | 245,000,000 | 245,000,000 | 245,000,000 | ||||
Ordinary share capital, shares outstanding (in shares) | 139,705,000 | 139,705,000 | 139,705,000 | ||||
Common stock, number of vote units per share | vote | 1 | 1 | |||||
Sale of stock, number of shares in transaction (in shares) | 23,000,000 | ||||||
Sale of stock, price per share (in USD per share) | $ / shares | $ 11.50 | ||||||
Sale of stock, gross consideration received on transaction | $ | $ 264.5 | ||||||
Stock repurchase program, number of shares authorized to be repurchased (in shares) | 150,000 | ||||||
Treasury stock, shares acquired (in shares) | 0 | 150,000 | 0 | 150,000 | |||
Treasury stock acquired, average price per share (in USD per share) | $ / shares | $ 6.97 | $ 6.97 | |||||
Stock repurchase program, remaining number of shares authorized to be repurchased (in shares) | 0 | 0 | |||||
RSU | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Share-based compensation arrangement, lock-up period, vesting period | 3 years | ||||||
Option | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Share-based compensation arrangement, lock-up period, vesting period | 3 years | ||||||
Share-based compensation arrangement, maximum contractual term | 5 years | ||||||
CEO Option awards | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Options granted during the period (in shares) | 850,000 | ||||||
Options forfeited during the period (in shares) | 756,000 | 756,000 | |||||
Granted, weighted average exercise price (in USD per share) | $ / shares | $ 10 | ||||||
Share-based compensation arrangement, performance criteria | criteria | 9 | ||||||
Awards exercisable (in shares) | 94,000 | 567,000 | 567,000 | ||||
Share-based compensation arrangement, performance criteria achieved | criteria | 1 | 1 | |||||
Awards outstanding (in shares) | 756,000 | ||||||
Expected future incremental compensation costs | $ | $ 1 | ||||||
2021 Plan | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Authorized shares (in shares) | 25,000,000 | 25,000,000 | |||||
2021 Plan | RSU | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
RSUs granted during the period (in shares) | 116,000 | ||||||
RSUs vested during the period (in shares) | 20,000 | ||||||
2021 Plan | Option | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Options granted during the period (in shares) | 3,500,000 | ||||||
Options forfeited during the period (in shares) | 124,000 | ||||||
2019 Plan | Employee | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||
Options exercised during the period (in shares) | 9,000 |
GOVERNMENT GRANTS (Details)
GOVERNMENT GRANTS (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Feb. 28, 2023 | Dec. 31, 2022 | |
Government Assistance [Line Items] | ||||||
Grant income | $ 0.1 | $ 0.6 | $ 0.1 | $ 2 | ||
Cost capitalized | 0 | $ 0 | 0 | $ 4.9 | ||
Deferred income from grants, short-term | 0.2 | 0.2 | $ 0.2 | |||
Deferred income from grants, long-term | 20 | 20 | $ 0 | |||
Giga America project | ||||||
Government Assistance [Line Items] | ||||||
Grant income | 0 | |||||
Deferred income from grants, long-term | $ 20 | $ 20 | ||||
Government grant, amount awarded | $ 20 |
INCOME TAXES (Details)
INCOME TAXES (Details) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate | 1% | 0% | 1% | 0% |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
May 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Related Party Transaction [Line Items] | ||||||
Related party transaction, general and administrative expense | $ 27,631 | $ 28,150 | $ 57,633 | $ 52,764 | ||
Accrued liabilities and other | 32,510 | 32,510 | $ 51,446 | |||
Cost capitalized | 0 | 0 | 0 | 4,900 | ||
Accounts payable | 20,162 | 20,162 | 6,765 | |||
Director | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction, term | 3 years | |||||
Related party transaction, monthly fee | $ 30 | |||||
Related party transaction, general and administrative expense | 100 | 200 | 200 | 300 | ||
Accrued liabilities and other | 100 | 100 | 100 | |||
Metier OEC | Related party | ||||||
Related Party Transaction [Line Items] | ||||||
Related party transaction, general and administrative expense | 1,000 | 1,500 | 2,600 | 2,600 | ||
Accrued liabilities and other | $ 700 | |||||
Cost capitalized | 500 | $ 0 | 1,300 | $ 100 | ||
Accounts payable | $ 600 | $ 600 |
NET (LOSS) INCOME PER SHARE - S
NET (LOSS) INCOME PER SHARE - Schedule of Basic and Diluted Net Loss per Share Attributable to Ordinary Shareholders (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Numerator: | ||||
Net (loss) income attributable to ordinary shareholders - basic | $ (25,282) | $ 4,671 | $ (38,008) | $ (30,236) |
Net (loss) income attributable to ordinary shareholders - diluted | $ (25,282) | $ 4,671 | $ (38,008) | $ (30,236) |
Denominator: | ||||
Weighted average ordinary shares outstanding - basic (in shares) | 139,705,000 | 116,830,000 | 139,705,000 | 116,842,000 |
Dilutive effect of EDGE Warrants and share-based compensation liability awards (in shares) | 0 | 2,420,000 | 0 | 0 |
Weighted average ordinary shares outstanding - dilutive (in shares) | 139,705,000 | 119,250,000 | 139,705,000 | 116,842,000 |
Net (loss) income attributable to ordinary shareholders per share: | ||||
Net (loss) income attributable to ordinary shareholders per share - basic (in USD per share) | $ (0.18) | $ 0.04 | $ (0.27) | $ (0.26) |
Net (loss) income attributable to ordinary shareholders per share - diluted (in USD per share) | $ (0.18) | $ 0.04 | $ (0.27) | $ (0.26) |
NET (LOSS) INCOME PER SHARE -_2
NET (LOSS) INCOME PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jul. 13, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 37,269 | 29,600 | 37,269 | 32,560 | ||
Share-based compensation liability awards | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Number of awards to be cash-settled (in shares) | 101 | 101 | ||||
Number of outstanding awards (in shares) | 668 | 668 | ||||
CEO option awards | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Number of outstanding awards (in shares) | 756 | |||||
Number of option awards excluded (in shares) | 756 | 756 | ||||
Number of CEO option awards (in shares) | 850 | |||||
Public Warrants | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 14,625 | 14,375 | 14,625 | 14,375 | ||
Private Warrants | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 10,000 | 10,250 | 10,000 | 10,250 | ||
EDGE warrants | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 2,176 | 0 | 2,176 | 2,176 | ||
Employee awards | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 9,240 | 4,881 | 9,240 | 4,881 | ||
Share-based compensation liability awards | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 567 | 0 | 567 | 784 | ||
CEO option awards | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
Total | 661 | 94 | 661 | 94 |